Target intelligence / Profile preview

WASP family homolog 2, pseudogene (WASH2P)

Target
WASH2P
Molecular classification
Pseudogene, WASP family (homology only; not functional), Other
01

Overview

WASH2P (WASP family homolog 2, pseudogene) is a non-protein-coding gene in humans, classified as a pseudogene due to the presence of disruptive mutations including premature stop codons, which prevent the formation of a functional protein[1][4]. Although it shares sequence similarity with WASP family proteins implicated in actin cytoskeleton regulation and intracellular trafficking, WASH2P does not produce a protein product and currently has no established physiological, disease, or therapeutic role[1][4]. Functional WASP family members—such as WASH1 (WASHC1)—are core components of the WASH complex, regulating Arp2/3-mediated actin polymerization and endosomal sorting, but WASH2P is not an active participant in these processes[2][3]. The gene is frequently misannotated as a potential target due to sequence similarity, but annotation efforts and proteomic data confirm that WASH2P does not contribute to the functional WASH complex in humans[2][4]. Note: WASH2P should not be selected as a drug target or biomarker, and confusion with protein-coding WASP family members (e.g., WASH1/WASHC1) must be avoided in research and drug development contexts.

Other names
WAS protein family homolog 2, pseudogeneWASH2PFAM39BMGC52000CXYorf1-like protein on chromosome 2Protein FAM39B
02

Mechanism of action

None applicable, as WASH2P does not encode a functional protein.

03

Biological functions

None known or confirmed for the pseudogene itself, due to lack of functional protein productFunctional WASP family proteins are involved in: Actin nucleationEndosomal transportCytoskeletal remodelingImmune synapse formation (for protein-coding WASP family members)
04

Disease associations

None established for WASH2P pseudogene itselfMutations in true WASP family genes are linked to neurological, developmental, and immunological disorders, but WASH2P specifically has no direct disease association
05

Safety considerations

None known for WASH2P. Therapeutic targeting is not feasible due to lack of functional expression.
06

Interacting drugs

None. There are no drugs targeting the WASH2P pseudogene.
07

Biomarkers

None relevant for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on WASP family homolog 2, pseudogene (WASH2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WASP family homolog 2, pseudogene (WASH2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call